Acquisition Completed Sponsor buyer

Consortium led by Robert A. Ortenzio, Martin F. Jackson and WCAS acquisition of Select Medical Holdings

US$3.9bn equity value

Announced 2 Mar 2026 · NYSE: SEM · US$16.50 cash per share · 18% premium

Advisers

Select Medical Holdings

Target

Financial adviser
Fairness opinion

Unnamed acquisition entity affiliated with the Select Medical consortium

Acquirer

Target
Select Medical Holdings
Acquirer
Unnamed acquisition entity affiliated with the Select Medical consortium
Sponsor
Welsh, Carson, Anderson & Stowe, Robert A. Ortenzio, Martin F. Jackson, WCAS XIV, L.P.
Target based in
United States
Buyer based in
United States
Completed
1 Jul 2026
Sector
Healthcare Services

In the league tables

Similar deals

All healthcare services deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.